| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $34.3B | $30.1B | $29.1B | $28.5B | $27.8B | $7.2B | $7.2B | $7.9B |
| Cost of Revenue | — | — | — | — | — | $5.0B | $4.8B | $5.5B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $2.5B | $2.2B | $2.3B | $2.0B | $2.0B | $1.9B | $1.8B | $0.4B |
| SG&A Expense | $5.7B | $4.9B | $5.2B | $4.9B | $4.9B | $4.6B | $4.9B | $1.2B |
| Operating Income | $-0.4B | $2.2B | $2.1B | $0.8B | $1.1B | $0.1B | $0.5B | $0.7B |
| Net Income | $0.1B | $2.6B | $2.0B | $0.9B | $3.4B | $-0.3B | $1.0B | $1.9B |
| EPS (Basic) | $-0.04 | $1.95 | $1.56 | $0.67 | $2.62 | $0.12 | $0.37 | $-0.52 |
| EPS (Diluted) | $-0.04 | $1.93 | $1.54 | $0.66 | $2.58 | $0.12 | $0.36 | $-0.52 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $75.9B | $71.3B | $57.2B | $57.1B | $57.7B | $54.0B | $51.8B | $55.5B |
| Current Assets | $25.0B | $33.5B | $18.9B | $20.5B | $18.9B | $16.6B | $15.1B | $17.3B |
| Cash & Equivalents | $5.8B | $14.8B | $4.3B | $4.2B | $4.0B | $4.2B | $3.8B | $4.9B |
| Total Liabilities | — | — | — | — | — | — | $14.3B | — |
| Current Liabilities | $24.6B | $26.0B | $21.9B | $23.2B | $20.7B | $18.7B | $19.2B | $17.2B |
| Stockholders' Equity | $24.7B | $24.8B | $21.2B | $19.9B | $20.0B | $16.0B | $17.1B | $21.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.9B | $4.3B | $4.4B | $4.6B | $5.9B | $2.2B | $4.0B | $3.0B |
| Investing Cash Flow | $-13.2B | $-0.1B | $-3.3B | $-2.1B | $-2.8B | $-2.6B | $-3.5B | $-2.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $1.0B | $6.3B | $-1.4B | $-1.8B | $-3.4B | $0.9B | $-1.5B | $-5.6B |